The New York State Department of Financial Services (NYDFS) has notified opioid manufacturers and distributors that it could file a civil enforcement action against them, accusing them of contributing to the surge in health insurance premiums in the state.
Sources close to the matter told Reuters that the regulator sent letters to about 23 opioid manufacturers and distributors, notifying each of them that the NYDFS would begin the process of holding a hearing on the issue in an administrative proceeding.
You've reached your limit - Register for free now for unlimited access
To read the full story, and get unlimited access to Insurance Business website content, just register for free now. GET STARTED HERE
Already a website member? Log in below.